Correlation Between Madrigal Pharmaceuticals and AnaptysBio
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and AnaptysBio, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and AnaptysBio.
Diversification Opportunities for Madrigal Pharmaceuticals and AnaptysBio
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Madrigal and AnaptysBio is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and AnaptysBio go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and AnaptysBio
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.86 times more return on investment than AnaptysBio. However, Madrigal Pharmaceuticals is 1.16 times less risky than AnaptysBio. It trades about 0.03 of its potential returns per unit of risk. AnaptysBio is currently generating about 0.02 per unit of risk. If you would invest 27,101 in Madrigal Pharmaceuticals on November 19, 2024 and sell it today you would earn a total of 6,619 from holding Madrigal Pharmaceuticals or generate 24.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. AnaptysBio
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| AnaptysBio |
Madrigal Pharmaceuticals and AnaptysBio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and AnaptysBio
The main advantage of trading using opposite Madrigal Pharmaceuticals and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |